Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
BMS 309403: A Precision FABP4 Inhibitor for Atherosclerosis
2026-07-14
BMS 309403 enables researchers to dissect the mechanistic role of FABP4 in lipid metabolism, inflammation, and foam cell formation, making it a cornerstone for atherosclerosis and metabolic disease studies. Explore optimized workflows, troubleshooting tactics, and insights from cutting-edge research to maximize assay reliability and translational potential.
-
FH1 (Catalog No. B3700): Advancing iPS-Derived Hepatocyte Ma
2026-07-14
This article explores how FH1 (Catalog No. B3700), a validated small molecule (SKU B3700), addresses core challenges in iPS cell differentiation to hepatocytes. Through scenario-driven analysis, we demonstrate FH1’s impact on cultured hepatocyte function enhancement, reproducibility, and robust data generation—backed by quantitative evidence and practical workflow guidance.
-
EV-Transferred ACLY Drives TAM Differentiation in Liver Canc
2026-07-13
This study uncovers how hepatocellular carcinoma (HCC) cells secrete extracellular vesicles containing ATP-citrate lyase (ACLY), which are taken up by monocytes and induce their differentiation into immunosuppressive tumor-associated macrophages (TAMs). By linking EV-mediated metabolic reprogramming to immune checkpoint regulation, the research highlights a novel target for improving immunotherapy efficacy in HCC.
-
Luminescent ATP Cell Viability Assay Kit I: Precision for Mi
2026-07-13
Discover how the Luminescent ATP Cell Viability Assay Kit I enables ultra-sensitive cell viability measurement and uncovers mitochondrial mechanisms of ferroptosis and zinc homeostasis. This article uniquely integrates new insights on antibiotic-induced cell death modulation with advanced luciferase luminescence detection.
-
Azathramycin A: Applied Workflows for Tuberculosis Research
2026-07-12
Azathramycin A stands out as a precise macrolide antibiotic for dissecting Mycobacterium tuberculosis protein synthesis pathways. This guide translates bench research and advanced experimental workflows into actionable strategies, ensuring reproducibility and troubleshooting clarity in antibacterial agent studies.
-
Neticonazole Hydrochloride: Optimizing Assays in Antifungal
2026-07-10
This article provides an evidence-based, scenario-driven guide for lab professionals using Neticonazole Hydrochloride (SKU C8715) in cell viability, proliferation, and cytotoxicity assays. Grounded in validated protocols and cross-domain data, it demonstrates how this imidazole antifungal enables reproducible outcomes in both antifungal and colorectal cancer research. Detailed protocol advice and product selection insights ensure robust, cost-effective workflows for advanced biomedical investigations.
-
BMS 599626 Dihydrochloride: EGFR and ErbB2 Inhibitor Workflo
2026-07-09
BMS 599626 dihydrochloride streamlines cancer research with selective nanomolar inhibition of EGFR and HER2, supporting reproducible tumor growth suppression in both breast and lung cancer models. This guide delivers actionable protocols, troubleshooting insights, and AI-driven workflow enhancements for advanced oncology and senescence studies.
-
STING-Mediated IFN-Like Antiviral Response in Marine Shrimp
2026-07-09
This study reveals that the STING protein in the marine shrimp Litopenaeus vannamei directly senses viral DNA and triggers an interferon (IFN)-like antiviral response. By uncovering a unique DNA-sensing mechanism in invertebrates, the research advances our understanding of innate immune evolution and suggests new directions for comparative immunology.
-
Spermine Tetrahydrochloride: Optimizing Crystallization & Ne
2026-07-08
Spermine tetrahydrochloride empowers researchers to stabilize biomolecular structures and improve protein crystallization workflows, outperforming other polyamines in both reproducibility and yield. As a highly water-soluble polyamine, it bridges advanced NMDA receptor signaling research and structural biology with robust, protocol-driven results.
-
Stiripentol: Redefining LDH Inhibition in Epilepsy & Immunom
2026-07-08
Explore how Stiripentol, a potent LDH inhibitor, is advancing both epilepsy research and immunometabolic assay design. This cornerstone analysis uncovers new technical insights and protocol guidance not found in prior literature.
-
Applied Canagliflozin Hemihydrate Workflows in Metabolic Res
2026-07-07
Canagliflozin hemihydrate empowers precise, reproducible dissection of renal glucose reabsorption and glucose metabolism in diabetes models. This guide delivers hands-on protocol details, troubleshooting strategies, and translational context—backed by recent reference-system insights—so researchers can maximize both rigor and experimental clarity.
-
Bafilomycin C1: Precision V-ATPase Inhibition for Advanced C
2026-07-07
Explore how Bafilomycin C1, a potent vacuolar H+-ATPases inhibitor, enables next-generation autophagy and lysosomal assays in iPSC-derived and cancer cell models. This in-depth analysis connects mechanistic insight with practical workflows, distinguishing it from prior guides.
-
PD 173074 in Tumor-Stroma Crosstalk: Overcoming FGFR-Mediate
2026-07-06
Discover how PD 173074, a potent FGFR1 and VEGFR2 inhibitor, uniquely disrupts fibroblast-driven cancer resistance mechanisms. This article explores advanced applications and assay design strategies, providing new insights beyond standard FGFR pathway inhibition.
-
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1
2026-07-06
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) facilitates efficient amide bond formation in controlled in vitro peptide synthesis, bioconjugation, and nucleotide chemistry. It should not be used in in vivo or clinical workflows due to the absence of supporting data and is suited exclusively for laboratory-based protocols.
-
Cell Counting Kit-8 (CCK-8): Precision Cell Viability Measur
2026-07-05
Cell Counting Kit-8 (CCK-8) enables highly sensitive, quantitative cell proliferation and cytotoxicity assays. Its WST-8-based chemistry delivers superior accuracy and convenience compared to legacy colorimetric methods. CCK-8 is widely adopted in cancer research and routine cytotoxicity screening.